Is Interaction of Amyloid β-peptides with Metals Involved in Cognitive Activity?
Overview
Authors
Affiliations
Metal ions, i.e., Zn(2+) and Cu(2+), are released from neuron terminals in the hippocampus, which plays important roles in spatial and declarative memory, and may serve as a signal factor. Synaptic homeostasis of metal ions is critical for cognitive activity in the hippocampus. Amyloid-β (Aβ) is a causative candidate for the pathogenesis of Alzheimer's disease (AD) and Aβ-induced synapse dysfunction is easy to emerge along with normal aging and leads to the cognitive decline and memory loss in the pre-dementia stage of AD. Because Aβ interacts with Zn(2+) and Cu(2+), it is likely that these metal ions are involved in the Aβ-induced modification of the synaptic function. There is evidence to indicate that the inhibition of the interaction of Aβ with Zn(2+) and Cu(2+) may ameliorate the pathophysiology of AD. Interaction of extracellular Zn(2+) with Aβ in the hippocampus is involved in transiently Aβ-induced cognition deficits, while the interaction of extracellular Cu(2+) reduces bioavailability of intracellular Cu(2+), followed by an increase in oxidative stress, which may lead to cognitive deficits. It is likely that Zn(2+) and Cu(2+) play as a key-mediating factor in pathophysiology of the synaptic dysfunction in which Aβ is involved. Based on the idea that understating Aβ-induced changes in synaptic plasticity is important to prevent AD, the present paper summarizes the interaction of Aβ with metal ions in cognition.
Big dynorphin is a neuroprotector scaffold against amyloid β-peptide aggregation and cell toxicity.
Gallego-Villarejo L, Wallin C, Krol S, Enrich-Bengoa J, Suades A, Aguilella-Arzo M Comput Struct Biotechnol J. 2022; 20:5672-5679.
PMID: 36284704 PMC: 9582793. DOI: 10.1016/j.csbj.2022.10.014.
Li Q, Zhou D, Tu Y, Wu X, Pei D, Xiong Y Exp Ther Med. 2022; 24(1):478.
PMID: 35761804 PMC: 9214599. DOI: 10.3892/etm.2022.11405.
The Function of Transthyretin Complexes with Metallothionein in Alzheimer's Disease.
Zareba N, Kepinska M Int J Mol Sci. 2020; 21(23).
PMID: 33256250 PMC: 7730073. DOI: 10.3390/ijms21239003.
Silymarin's Inhibition and Treatment Effects for Alzheimer's Disease.
Guo H, Cao H, Cui X, Zheng W, Wang S, Yu J Molecules. 2019; 24(9).
PMID: 31064071 PMC: 6539875. DOI: 10.3390/molecules24091748.
Piscopo M, Trifuoggi M, Scarano C, Gori C, Giarra A, Febbraio F Sci Rep. 2018; 8(1):7414.
PMID: 29743544 PMC: 5943286. DOI: 10.1038/s41598-018-25784-z.